Tag: Mount Sinai Health System

Atopic Dermatitis (Eczema)

Oral Medication Shows Strong Promise for Moderate to Severe Eczema in...

Upadacitinib yielded rapid and significant improvements in patients with moderate to severe atopic dermatitis in phase 3 trials.
Epitope Mapping

Mount Sinai and AllerGenis Announce Partnership to Bring Novel, Precision Diagnostics...

The technology will provide an improved method for detecting, assessing, and monitoring food allergies in patients.